UK Markets closed

Allergy Therapeutics plc (AGY.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
30.81-0.19 (-0.61%)
At close: 04:36PM GMT
Currency in GBp

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.57
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 340.50
52-week low 317.75
50-day moving average 333.93
200-day moving average 330.08

Share statistics

Avg vol (3-month) 3308.23k
Avg vol (10-day) 3654.48k
Shares outstanding 5641.8M
Implied shares outstanding 6N/A
Float 8353.57M
% held by insiders 1100.55%
% held by institutions 16.86%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 30 Jun 2021
Most-recent quarter (mrq)30 Jun 2021

Profitability

Profit margin 3.42%
Operating margin (ttm)4.66%

Management effectiveness

Return on assets (ttm)2.81%
Return on equity (ttm)6.25%

Income statement

Revenue (ttm)84.33M
Revenue per share (ttm)0.13
Quarterly revenue growth (yoy)9.30%
Gross profit (ttm)62.23M
EBITDA 6.11M
Net income avi to common (ttm)2.89M
Diluted EPS (ttm)0.40
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)40.27M
Total cash per share (mrq)0.06
Total debt (mrq)11.17M
Total debt/equity (mrq)23.02
Current ratio (mrq)3.17
Book value per share (mrq)0.08

Cash flow statement

Operating cash flow (ttm)8.4M
Levered free cash flow (ttm)5.55M